Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid
- 1 October 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (12) , 2075-2080
- https://doi.org/10.1016/s0959-8049(97)00242-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The efficacy of 9-cis retinoic acid in experimental models of cancerBreast Cancer Research and Treatment, 1996
- Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic AcidJNCI Journal of the National Cancer Institute, 1996
- Gene expression and neuroblastoma cell Differentiation in response to retinoic acid: Differential effects of 9-cis and all-trans retinoic acidEuropean Journal Of Cancer, 1995
- Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitroNeuroscience Letters, 1994
- Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell lineCancer Letters, 1993
- Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cellsFEBS Letters, 1993
- Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosisInternational Journal of Cancer, 1992
- Homodimer formation of retinoid X receptor induced by 9-cis retinoic acidNature, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Observations on the histopathology of neuroblastomasJournal of Pediatric Surgery, 1968